Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Gilead Sciences to Acquire MiroBio
Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company focused on restoring […]
Radiopharm Enters Into Strategic Collaboration With Lantheus and Assumes PD-L1 Licensing Agreement From Nanomab
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical […]
Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)
Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer. An experienced science and business […]
H1 and Lokavant Partner on Data and Analytics to Power Next Generation Clinical Trials
H1, the connecting force for global HCP, clinical, scientific, and research information, and Lokavant, the […]
Eleven Therapeutics Announces $22 Million in Seed Funding
Eleven Therapeutics, a biotechnology company leading the AI revolution in nucleic acid therapeutics, announced today […]
Verana Health Fuels for Growth with the Appointment of Chris Reiling as Chief Revenue Officer and Lawrence Whittle as Chief Commercial Officer
Verana Health®—a digital health company elevating quality in real-world data—today announced the appointments of Chris Reiling as […]
Regard and TidalHealth Partner To Fight Clinician Burnout Through AI-Driven Workflows
Regard, a software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose […]
Advanced Instruments Acquires SAL Scientific, Expertise, and a Range of Cell Growth Supplements in Support of Research & Drug Discovery Workflows
Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the […]
OriCell Therapeutics Raises Over $120 Million in Series B Financing Led by Qiming Venture Partners and Quan Capital to Advance Cell Therapies for Cancer Immunology
OriCell Therapeutics (Shanghai) Co., Ltd. (“OriCell” or “the Company”) has announced the completion of Series B […]
Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer
Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more